Skip to the page

Data / Form D filings / RxWare, Inc.

RxWare, Inc.: Form D filings

RxWare, Inc., a health care company in Wilmington, DE, filed 4 Form D notices with the SEC between 2019 and 2025. The latest, on August 14, 2025, reports $6.1 million sold of a $6.7 million offering to 12 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1313 NORTH MARKET STREET, SUITE 1000, Wilmington, DE, 19801
Phone
(218) 392-4373
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1790134

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 14, 2025New notice$6,744,266$6,144,268$599,99812Aug 1, 2025sec.gov
Dec 2, 2024New notice$1,175,000$225,000$950,0003Nov 15, 2024sec.gov
May 7, 2024New notice$1,000,000$700,000$300,0004Apr 22, 2024sec.gov
Oct 4, 2019New notice$6,000,000$3,620,000$2,380,0004Sep 19, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David MatiasDirector
Raeanna LewarneExecutive Officer, Director
Shlomi AflaloExecutive Officer, Director
Harry TotonisDirector
Farhan AshrafDirector
Adam FineDirector

Other health care companies in Delaware that filed recently

Every Form D from the week of Aug 11, 2025 · All recent filings in Delaware · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what RxWare, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.